Silvaco Group, Inc.
For the period ended Mar 31, 2025. Filed May 7, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 7, 2025
SVCO$7.25+3.1%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Statements of Cash Flows
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited, in thousands)
| Three Months Ended March 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Cash flows from operating activities: | ||
| Net (loss) income | $(19,273) | $1,378 |
| Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities: | ||
| Depreciation and amortization | 438 | 120 |
| Stock-based compensation expense | 2,277 | — |
| Provision for credit losses | 10 | 222 |
| Estimated litigation claim | 13,069 | — |
| Accretion of discount on marketable securities, net | (261) | — |
| Change in fair value of contingent consideration | 35 | (8) |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | 3,520 | (1,844) |
| Contract assets | 440 | (3,679) |
| Prepaid expenses and other current assets | (1,026) | 788 |
| Other assets | 119 | (274) |
| Accounts payable | (1,183) | 877 |
| Accrued expenses and other current liabilities | 55 | (729) |
| Accrued income taxes | 58 | 574 |
| Deferred revenue | 567 | (21) |
| Other non-current liabilities | 20 | 24 |
| Net cash used in operating activities | (1,135) | (2,572) |
| Cash flows from investing activities: | ||
| Maturities of marketable securities | 23,000 | — |
| Acquisition of Process Proximity Compensation | (11,500) | — |
| Purchases of property and equipment | (96) | (10) |
| Net cash provided by (used in) investing activities | 11,404 | (10) |
| Cash flows from financing activities: | ||
| Proceeds from loan facility | — | 4,250 |
| Deferred transaction costs | — | (364) |
| Payroll taxes related to shares withheld from employees | (252) | — |
| Contingent consideration | (46) | (13) |
| Payments of vendor financing obligation | (205) | — |
| Net cash (used in) provided by financing activities | (503) | 3,873 |
| Effect of exchange rate fluctuations on cash and cash equivalents | 117 | 27 |
| Net increase in cash and cash equivalents | 9,883 | 1,318 |
| Cash and cash equivalents, beginning of period | 19,606 | 4,421 |
| Cash and cash equivalents, end of period | $29,489 | $5,739 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.